Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Fr Ophtalmol ; 41(8): 752-758, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-30217604

RESUMEN

PURPOSE: To compare the efficacy of two surgical techniques-lateral tarsal strip (canthoplasty) alone, and lateral tarsal strip with three-snip punctoplasty-in reducing epiphora arising from involutional ectropion with partial punctal stenosis. METHODS: Fourty patients with involutional ectropion and partial stenosis of the lacrimal punctum were randomly allocated to two treatment groups. Group 1 patients received lateral tarsal strip alone with only non-invasive stenting of the punctum, and group 2 patients received tarsal strip plus three-snip punctoplasty. Subjective assessment of epiphora was achieved via completion of a quality of life (QoL) questionnaire preoperatively and at postoperative month 3. Eyelid position, adverse outcomes and corneal dryness (via Oxford grading scheme) were also assessed postoperatively. Only patients with unilateral problems were included in the study. RESULTS: Forty eyes of 40 patients were included: 20 in each group. The mean ages of group 1 and group 2 patients were 79±11 and 80±9 years, respectively. All patients reported significantly reduced eye watering after surgery, with no significant intergroup difference in subjective outcomes, except that computer usage and night driving (P<0.05), improved in a more significant way in group 2. Eyelid malposition was corrected in all cases, there were no cases of postoperative punctal eversion, and no significant adverse events or complications occurred. Finally, the mean improvements in the dryness/keratitis score (using the Oxford scheme) were comparable between the 2 groups (P=0.34). CONCLUSION: The study findings indicate that treatment of involutional ectropion with partial punctal stenosis by lateral tarsal strip with three snip punctoplasty does not provide greater reduction in discomfort secondary to epiphora than conventional lateral tarsal strip alone, except for specific situations such as night driving or computer use.


Asunto(s)
Ectropión/cirugía , Párpados/cirugía , Aparato Lagrimal/cirugía , Procedimientos Quirúrgicos Oftalmológicos/métodos , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Obstrucción del Conducto Lagrimal/prevención & control , Masculino , Calidad de Vida , Encuestas y Cuestionarios , Resultado del Tratamiento
2.
J Fr Ophtalmol ; 40(9): 744-750, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-29050928

RESUMEN

PURPOSE: To compare the impact of two phacoemulsification techniques (subluxation versus divide-and-conquer) on postoperative corneal edema at postoperative hour 1 and day 4. DESIGN: Comparative study. METHOD: Ninety-six consecutive patients (110 eyes; 43 men and 53 women, mean age 70.9±9.8 years) with equivalent cataract grades underwent cataract surgery and were followed up for 6 months. The presence of corneal edema was determined using central corneal thickness (CCT). CCT was measured preoperatively, and at postoperative hour 1 and day 4. MAIN OUTCOME MEASURES: Ultrasound power (US %), duration of ultrasound (TPA), effective ultrasound time (TPE), surgical duration and final suture (%). RESULTS: Eyes of participants were divided into two phacoemulsification technique groups: subluxation (n=50 eyes) and divide-and-conquer (n=60 eyes). Non-inferiority analysis revealed similar CCT increases at postoperative hour 1 in both groups, with 69.9±44.9µm and 64.4±42.9µm, observed in the subluxation and divide-and-conquer groups, respectively (P=0.033). TPE was similar in both groups, taking 6.2±3.4 and 7.3±4.5seconds in the subluxation and divide-and-conquer groups, respectively (P=0.150). No correlation was seen between TPE and edema at postoperative hour 1, or between TPE and day 4 edema. Rate of final suture use was similar between the subluxation and divide and conquer groups, at 36% and 30%, respectively. CONCLUSION: The study findings suggest that cataract surgery performed using the subluxation technique does not result in greater CCT than the divide-and-conquer technique. CCT appears to normalize by postoperative day 4, regardless of the technique used.


Asunto(s)
Paquimetría Corneal , Facoemulsificación/efectos adversos , Facoemulsificación/métodos , Complicaciones Posoperatorias/diagnóstico , Anciano , Anciano de 80 o más Años , Extracción de Catarata/efectos adversos , Extracción de Catarata/métodos , Córnea/diagnóstico por imagen , Córnea/fisiopatología , Córnea/cirugía , Femenino , Humanos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/etiología , Periodo Posoperatorio , Agudeza Visual
3.
J Neuroimmunol ; 227(1-2): 71-9, 2010 Oct 08.
Artículo en Inglés | MEDLINE | ID: mdl-20637510

RESUMEN

Glatiramer acetate (GA) is an immunomodulator approved for therapy of relapsing-remitting multiple sclerosis (RRMS), but recent findings indicate that it may also have additional, neurotrophic effects. Here, we found that supernatants from human GA-reactive T lymphocytes potentiated oligodendrocyte numbers in rodent and human oligodendrocyte progenitor (OPC) cultures. Effects of Th2-polarized lines were stronger than Th1-polarized cells. Microarray and ELISA analyses revealed that neurotrophic factors induced in Th2- and Th1-polarized GA-reactive lines included IGF-2 and BMP-7 respectively, and functional studies confirmed IGF-2 as trophic for OPCs. Our results support the concept that GA therapy may result in supportive effects on oligodendrocytes in RRMS patients.


Asunto(s)
Adyuvantes Inmunológicos/fisiología , Factor II del Crecimiento Similar a la Insulina/fisiología , Oligodendroglía/inmunología , Péptidos/fisiología , Células Madre/inmunología , Células Madre/fisiología , Células Th2/inmunología , Adyuvantes Inmunológicos/uso terapéutico , Animales , Línea Celular Tumoral , Linaje de la Célula/inmunología , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Acetato de Glatiramer , Humanos , Recuento de Linfocitos/métodos , Ratones , Esclerosis Múltiple Recurrente-Remitente/tratamiento farmacológico , Esclerosis Múltiple Recurrente-Remitente/inmunología , Esclerosis Múltiple Recurrente-Remitente/patología , Oligodendroglía/citología , Oligodendroglía/efectos de los fármacos , Péptidos/uso terapéutico , Células Madre/citología , Células Madre/efectos de los fármacos , Células Th2/citología , Células Th2/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...